Pliant Therapeutics OverviewPliant Therapeutics Other Income Expense Net
Other Income/Expense Net for PLRX.
Quarterly Other Income/Expense
$1.73M
↓ 37.45% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$3.49M
↓ 77.31% YoY
Trailing 12 months ending Mar 31, 2026